These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21952832)

  • 21. A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women.
    Enjuanes A; Garcia-Giralt N; Supervía A; Nogués X; Ruiz-Gaspà S; Bustamante M; Mellibovsky L; Grinberg D; Balcells S; Díez-Pérez A
    Bone; 2006 May; 38(5):738-43. PubMed ID: 16344016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.
    Rodríguez-Sanz M; García-Giralt N; Prieto-Alhambra D; Servitja S; Balcells S; Pecorelli R; Díez-Pérez A; Grinberg D; Tusquets I; Nogués X
    J Mol Endocrinol; 2015 Aug; 55(1):69-79. PubMed ID: 26108486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. -1227C>T polymorphism in the pleiotrophin gene promoter influences bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Komadina R; Vindišar F; Marc J
    Mol Genet Metab; 2011 May; 103(1):76-80. PubMed ID: 21353611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
    Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
    Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.
    Napoli N; Rastelli A; Ma C; Yarramaneni J; Vattikutti S; Moskowitz G; Giri T; Mueller C; Kulkarny V; Qualls C; Ellis M; Armamento-Villareal R
    Bone; 2013 Aug; 55(2):309-14. PubMed ID: 23643682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.
    Somner J; McLellan S; Cheung J; Mak YT; Frost ML; Knapp KM; Wierzbicki AS; Wheeler M; Fogelman I; Ralston SH; Hampson GN
    J Clin Endocrinol Metab; 2004 Jan; 89(1):344-51. PubMed ID: 14715870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of RMND1/CCDC170-ESR1 single nucleotide polymorphisms with hip fracture and osteoporosis in postmenopausal women.
    Hidalgo-Bravo A; Parra-Torres AY; Casas-Avila L; Jimenez-Ortega RF; Ramírez-Salazar EG; Patiño N; Rivera-Paredez B; Salmerón J; Valdés-Flores M; Velázquez-Cruz R
    Climacteric; 2019 Feb; 22(1):97-104. PubMed ID: 30601066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of rs749292 and rs700518 polymorphisms in the aromatase gene (CYP19A1) with osteoporosis in postmenopausal Polish women.
    Kamiński A; Bogacz A; Górska-Paukszta M; Seremak-Mrozikiewicz A; Czerny B
    Adv Clin Exp Med; 2019 Aug; 28(8):1067-1071. PubMed ID: 30855728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of IL-15 polymorphisms with bone mineral density in postmenopausal Korean women.
    Koh JM; Oh B; Ha MH; Cho KW; Lee JY; Park BL; Shin HD; Bae MA; Kim HJ; Hong JM; Kim TH; Shin HI; Lee SH; Kim GS; Kim SY; Park EK
    Calcif Tissue Int; 2009 Nov; 85(5):369-78. PubMed ID: 19756346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women.
    Ramesh Babu L; Wilson SG; Dick IM; Islam FM; Devine A; Prince RL
    Bone; 2005 Mar; 36(3):555-61. PubMed ID: 15777683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VDR polymorphisms are associated with bone mineral density in post-menopausal Mayan-Mestizo women.
    Canto-Cetina T; Cetina Manzanilla JA; González Herrera L; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Canto P
    Ann Hum Biol; 2015; 42(5):470-5. PubMed ID: 25347090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures.
    Jurado S; Nogués X; Agueda L; Garcia-Giralt N; Urreizti R; Yoskovitz G; Pérez-Edo L; Saló G; Carreras R; Mellibovsky L; Balcells S; Grinberg D; Díez-Pérez A
    Osteoporos Int; 2010 Feb; 21(2):287-96. PubMed ID: 19436932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.
    Ota N; Nakajima T; Nakazawa I; Suzuki T; Hosoi T; Orimo H; Inoue S; Shirai Y; Emi M
    J Hum Genet; 2001; 46(5):267-72. PubMed ID: 11355017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms and haplotypes of integrinalpha1 (ITGA1) are associated with bone mineral density and fracture risk in postmenopausal Koreans.
    Lee HJ; Kim SY; Koh JM; Bok J; Kim KJ; Kim KS; Park MH; Shin HD; Park BL; Kim TH; Hong JM; Park EK; Kim DJ; Oh B; Kimm K; Kim GS; Lee JY
    Bone; 2007 Dec; 41(6):979-86. PubMed ID: 17931993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland.
    Giraudeau FS; McGinnis RE; Gray IC; O'Brien EJ; Doncaster KE; Spurr NK; Ralston SH; Reid DM; Wood J
    J Bone Miner Res; 2004 Jan; 19(1):31-41. PubMed ID: 14753734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis.
    Mullin BH; Prince RL; Dick IM; Hart DJ; Spector TD; Dudbridge F; Wilson SG
    Am J Hum Genet; 2008 Jun; 82(6):1262-9. PubMed ID: 18499081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women.
    Rendina D; Gianfrancesco F; De Filippo G; Merlotti D; Esposito T; Mingione A; Nuti R; Strazzullo P; Mossetti G; Gennari L
    Eur J Endocrinol; 2010 Jul; 163(1):165-72. PubMed ID: 20335500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of RANK gene C421T and C575T polymorphisms with bone mineral density in postmenopausal Turkish women.
    Işleten B; Durmaz B; Durmaz B; Onay H; Ozkınay F; Durmaz A; Turan V; Oztekin K
    Arch Gynecol Obstet; 2013 Oct; 288(4):917-23. PubMed ID: 23553199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.
    Flote VG; Furberg AS; McTiernan A; Frydenberg H; Ursin G; Iversen A; Lofteroed T; Ellison PT; Wist EA; Egeland T; Wilsgaard T; Makar KW; Chang-Claude J; Thune I
    Breast Cancer Res; 2014 Dec; 16(6):499. PubMed ID: 25522654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women.
    Valero C; Zarrabeitia MT; Hernández JL; Pineda B; Cano A; García-Pérez MA; Riancho JA
    Menopause; 2011 Jul; 18(7):802-7. PubMed ID: 21441835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.